Clinical Trial Update: An Evaluation of Treatment of Amblyopia in Children 7 To <18 Years Old [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on amblyopia treatment in children aged 7 to under 18 years, with the study status listed as COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amblyopia

Snippet

Sponsor: Jaeb Center for Health Research | Conditions: Amblyopia | Phase 3 | Status: COMPLETED